Bo Sun
@neuro-bo.bsky.social
NIHR Academic Clinical Lecturer in Neurology
Brain Tumour Charity Future Leaders Fellow
Interested in neuroimmunology and neuro-oncology
Websites:
https://www.ndcn.ox.ac.uk/team/bo-sun
https://github.com/Nusob888
Brain Tumour Charity Future Leaders Fellow
Interested in neuroimmunology and neuro-oncology
Websites:
https://www.ndcn.ox.ac.uk/team/bo-sun
https://github.com/Nusob888
Reposted by Bo Sun
📢 NEW RESEARCH: how the body’s own defenses can mistakenly turn against the brain in CASPR2-antibody encephalitis 🧠
The findings potentially open the door to more targeted treatments.
Find out more 👉 tinyurl.com/2tftusd4
@neuro-bo.bsky.social
The findings potentially open the door to more targeted treatments.
Find out more 👉 tinyurl.com/2tftusd4
@neuro-bo.bsky.social
May 29, 2025 at 11:01 AM
📢 NEW RESEARCH: how the body’s own defenses can mistakenly turn against the brain in CASPR2-antibody encephalitis 🧠
The findings potentially open the door to more targeted treatments.
Find out more 👉 tinyurl.com/2tftusd4
@neuro-bo.bsky.social
The findings potentially open the door to more targeted treatments.
Find out more 👉 tinyurl.com/2tftusd4
@neuro-bo.bsky.social
Reposted by Bo Sun
www.nature.com/articles/s41...
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade - Nature Medicine
Analysis of multiple cohorts of patients with melanoma demonstrates a positive association between cytomegalovirus serostatus and overall survival in patients treated with monotherapy but not combinat...
www.nature.com
April 23, 2025 at 11:11 AM
www.nature.com/articles/s41...
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.